Steris | STE - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
3M USD 4.89B 1.62B 2026-06
Accuray USD 37.18M 567K 2024-12
Baxter International USD 2.68B 3.36B 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 4.2B 49M 2026-06
CONMED USD 307.08M 15.45M 2026-06
Cooper Companies USD 844.2M 268.3M 2026-06
Dexcom USD 990.1M 53.5M 2026-06
Ecolab USD 3.61B 220M 2026-06
Edwards Lifesciences USD 1.22B 87.6M 2026-06
Fortive USD 886.9M 9.2M 2026-06
Getinge SEK 7.03B 2.96B 2026-06
Globus Medical USD 835.58M 239.73M 2026-06
Haemonetics USD 145.34M 148.66M 2026-06
Idexx Laboratories USD 791.02M 12.78M 2026-06
Inogen USD 49.14M 665K 2024-09
Insulet USD 672M 32.3M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
Intuitive Surgical USD 1.91B 3.6M 2026-06
J&J USD 18.93B 1.09B 2026-09
Olympus JPY 210.33B 58.09B 2026-06
Orthofix International USD 213.79M 12.36M 2025-12
Owens Minor USD -550.94M 86.17M 2026-06
ResMed USD 1.01B 83.57M 2026-06
Steris USD 1.21B 62.8M 2026-06
Stryker USD 4.8B 118M 2026-06
Tandem Diabetes Care USD 268.35M 3.7M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Zimmer Biomet Holdings USD 1.83B 140.7M 2026-06